Behavior of tumor necrosis factor-α and tumor necrosis factor receptor 1/tumor necrosis factor receptor 2 system in mononuclear cells recovered from peritoneal fluid of women with endometriosis at different stages

Reproductive Sciences

Volumn 22, Issue 2, 2015, Pages 165-172

  Salmeri, Francesca M ^a   Laganà, Antonio Simone ^a   Sofo, Vincenza ^a   Triolo, Onofrio ^a   Sturlese, Emanuele ^a   Retto, Giovanni ^a   Pizzo, Alfonsa ^a   D'Ascola, Angela ^a   Campo, Salvatore ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Endometriosis; PFMCs; TNF ; TNFR1; TNFR2

Indexed keywords

MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; TNFRSF1A PROTEIN, HUMAN; TNFRSF1B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIOSIS; FEMALE; FEMALE INFERTILITY; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MONONUCLEAR CELL; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; APOPTOSIS; ASCITES FLUID; CASE CONTROL STUDY; CELL CULTURE; CELL PROLIFERATION; COMPARATIVE STUDY; CYTOLOGY; DISEASE COURSE; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; UPREGULATION; YOUNG ADULT;

ADULT; APOPTOSIS; ASCITIC FLUID; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELLS, CULTURED; DISEASE PROGRESSION; ENDOMETRIOSIS; FEMALE; HUMANS; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; YOUNG ADULT;

EID: 84920797322     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719114536472     Document Type: Article

References (25)

1. Bulun SE, Gurates B, Fang Z, et al. Mechanisms of excessive estrogen formation in endometriosis. J Reprod Immunol. 2002;55(1-2):21-33.
2. Baldi A, Campioni N, Signorile PG. Endometriosis: pathogenesis, diagnosis, therapy and association with cancer. Oncol Rep. 2008;19(4):843-846.
3. Bulun SE. Endometriosis. N Engl J Med. 2009;360(3):268-279.
4. Arici A, Oral E, Attar E, Tazuke SI, Olive DL. Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells. Fertil Steril. 1997;67(6):1065-1072.
5. Braun DP, Ding J, Shen J, Rana N, Fernandez BB, Dmowski WP. Relationship between apoptosis and the number of macrophages in eutopic endometrium from women with and without endometriosis. Fertil Steril. 2002;78(4):830-835.
6. Pizzo A, Salmeri FM, Ardita FV, Sofo V, Tripepi M, Marsico S. Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecol Obstet Invest. 2002;54(2):82-87.
7. Cao X, Yang D, Song M, Murphy A, Parthasarathy S. The presence of endometrial cells in the peritoneal cavity enhances monocyte recruitment and induces inflammatory cytokines in mice: implications for endometriosis. Fertil Steril. 2004;82(suppl 3):999-1007.
8. Tariverdian N, Siedentopf F, Rücke M, et al. Intraperitoneal immune cell status in infertile women with and without endometriosis. J Reprod Immunol. 2009;80(1-2):80-90.
9. Kalu E, Sumar N, Giannopoulos T, et al. Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis. J Obstet Gynaecol Res. 2007;33(4):490-495.
10. Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789-1799.
11. Ulukus M, Arici A. Immunology of endometriosis. Minerva Ginecol. 2005;57(3):237-248.
12. Harada T, Taniguchi F, Izawa M, et al. Apoptosis and endometriosis. Front Biosci. 2007;12:3140-3151.
13. Agic A, Djalali S, Diedrich K, et al. Apoptosis in endometriosis. Gynecol Obstet Inves. 2009;68(4):217-233.
14. Sturlese E, Salmeri FM, Retto G, et al. Dysregulation of the Fas/FasL system in mononuclear cells recovered from peritoneal fluid of women with endometriosis. J Reprod Immunol 2011;92(1-2):74-81.
15. Cabal-Hierro L, Lazo PS. Signal transduction by tumor necrosis factor receptors. Cell Signal. 2012;24(6):1297-1305.
16. Richter C, Messerschmidt S, Holeiter G, et al. The tumor necrosis factor receptor stalk regions define responsiveness to soluble versus membrane-bound ligand. Mol Cell Biol. 2012;32(13):2515-2529.
17. Koga K, Osuga Y, Tsutsumi O, et al. Increased concentrations of soluble tumour necrosis factor receptor (sTNFR) I and II in peritoneal fluid from women with endometriosis. Mol Hum Reprod. 2000;6(10):929-933.
18. American Society for Reproductive Medicine. Revised American society for reproductive medicine classification of endometriosis. Fertil Steril. 1996;67(5):817-821.
19. Yoshino O, Osuga Y, Koga K, et al. Concentrations of interferon-γ-induced protein-10 (IP-10), an antiangiogenic substance, are decreased in peritoneal fluid of women with advanced endometriosis. Am J Reprod Immunol. 2003;50(1):60-65.
20. Oosterlynck DJ, Meuleman C, Waer M, Vandeputte M, Koninckx PR. The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril. 1992;58(2):290-295.
21. Siegel S, Castellan NJ. Nonparametric Statistics for Behavioural Science. eds. London, UK: McGraw-Hill Education; 1988.
22. Micheau O, Tschopp J. Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes. Cell. 2003;114(2):181-190.
23. Haider S, Knofler M. Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta. 2009;30(2):111-123.
24. Tchikov V, Bertsch U, Fritsch J, Edelmann B, Schütze S. Subcellular compartmentalization of TNF receptor-1 and CD95 signaling pathways. Eur J Cell Biol. 2011;90(6-7):467-475.
25. Rossol M, Meusch U, Pierer M, et al. Interaction between Transmembrane TNF and TNFR1/2 mediates the activation of monocytes by contact with T cells. J Immunol. 2007;179(6):4239-4248.